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Abstract
Whole cigarette smoke (WCS) is composed of approximately 5% particulates and 95% vapors by
weight and is difficult to reproduce quantitatively in the laboratory, where typically, routine in
vitro application of smoke normally only utilizes the particulate phase. In this study, we used a
system for exposing epithelial cells cultured at an air-liquid interface to WCS. We hypothesized
that the use of WSC in vitro was more relevant to what is seen in vivo than methods of cigarette
smoke application that only use a small fraction of WCS [i.e., aqueous extract or cigarette smoke
condensate (CSC)]. To test this hypothesis, we compared nicotine and cotinine concentrations
(measured by mass spectrometry) in the airway surface liquid (ASL) of human primary bronchial
epithelial cultures (HBECs) exposed to serial dilutions of WCS to the concentrations found in
induced sputum of human subjects who had recently smoked a cigarette; this was also compared
to the concentrations found after an exposure to a concentration of CSC commonly used in vitro.
When measured by mass spectrometry, nicotine levels were not significantly different in induced
sputum versus the ASL of HBECs exposed in vitro to a 1:30 exposure of WCS. However, HBECs
that had been exposed to CSC returned significantly lower concentrations of ASL nicotine. These
results suggest that nicotine is a good dosimetry marker of WCS exposure and provides direct
evidence that the use of WCS is more relevant than the use of CSC for in vitro systems.
Introduction
Cigarette smoke-dependent chronic obstructive pulmonary disease and lung cancer are a
major cause of worldwide morbidity, and as a consequence, they are highly researched.
However, although the International Standards Organization (ISO) dictates the way a
cigarette should be smoked (i.e., a standard ‘puff’ is a 35-mL draw over 2 s), no established
protocols regarding how in vitro cell culture models should be exposed to cigarette smoke
exist. This confusion arises in part from the fact that cigarette smoke is difficult to study
because of the complexity of its constituent parts, with over 2000 different compounds being
produced per puff (1). The majority (95%) of whole cigarette smoke (WCS) is gaseous
phase by weight, with the remainder (5%) being particulates. The particulate phase is a
mixture of lipid-soluble and water-soluble particulates. The particulate phase and the
gaseous phase have been shown to have different properties. For example, a 1985 study by
Church and Pryor (2) showed that the gaseous phase itself contains a strong oxidizing
component that dominates, and the particulate phase is highly reductive. Because of the ease
of collection, the most common methods of collecting cigarette smoke extract include
passing WCS through Ringers solution to collect the aqueous phase or sonicating a WCS-
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exposed filter pad (a standard glass-fiber Cambridge filter pad that retains 99.9% of all
particulate matter with a size greater than 0.1 μm) in dimethyl sulfoxide (DMSO) to collect
the lipid soluble phase (CSC). These methods collect a small fraction (< 5%) of WCS, whilst
smokers inhale all the components of WCS. However, these methods have the advantage of
being relatively reproducible with dosing and are less complex than gas mixtures.
Measurements have previously been made of nicotine and its metabolites in urine and saliva
by mass spectrometry (MS) (3–5). However, no measurements have been made of WCS
metabolites in airway surface liquid (ASL). Recent studies demonstrating an effect of WCS
on airway ion transport have indicated a precise need for dosing of cigarette smoke at the
apical membrane of airway epithelia (6,7). Thus, we set out to measure WCS in ASL in vivo
versus in vitro using nicotine and cotinine as markers. ASL may be sampled in vivo using
the induced sputum technique. This method has previously been shown to selectively sample
ASL from the surfaces of the bronchial airways and limits contamination from saliva [i.e., it
is comparable to ASL in vivo (8)]. ASL may also be sampled in vitro by lavaging cultures
with Ringers solution, which has previously been shown to accurately sample ASL (9).
To expose human primary bronchial epithelial cultures (HBECs) to smoke, cultures were
placed in a specially designed Perspex smoke exposure chamber (Figure 1) that allows the
cultures to be exposed to WCS whilst maintaining an air-liquid interface and exposing the
serosal surface of the cultures to flowing media to maintain a physiologic environment (10).
We then compared induced sputum collected immediately after subjects had smoked one
cigarette to ASL sampled by lavage following WCS (from one cigarette). To achieve this,
we used a high-performance liquid chromatography–triple-quadrupole MS method (HPLC–
MS–MS) for the determination of low nanomolar concentrations of nicotine and its
breakdown product, cotinine, as cotinine levels are known to be directly related to nicotine
absorption (11). As a control, we also tested a commonly used dose of cigarette smoke
condensate (CSC). Thus, the goal of this study was to directly test whether the delivery of
WCS or the gaseous phase of cigarette smoke (GPCS) to airway epithelial cells were more
comparable to the in vivo situation than previously used smoke preparations.
Experimental Methods
Collection of induced sputum
All subjects smoked a full cigarette (various commercial brands) immediately (within 5 min)
prior to sputum induction. Sputum induction and processing were carried out as previously
outlined (8). Briefly, the induction procedure involved three separate 7 min inhalation
periods of 3%, 4%, and 5% hypertonic saline administered after baseline spirometry. At the
end of each 7-min inhalation period, subjects performed a three-step cleansing procedure to
remove saliva before a cough attempt as follows: 1. the mouth was rinsed and gargled with
water, 2. the back of the throat was cleared (without coughing), and 3. the nose was blown.
The subject was then instructed to perform a chesty-type cough without clearing the back of
the throat. The sample was expectorated into a sterile specimen cup that was placed on ice
throughout the procedure. The time between smoking and sample collection was
approximately a total of 20 min. Samples were kept at −20°C until processed; they were
then treated with 0.1% dithiothreitol to disperse mucus, washed with DPBS buffer (5 min, at
room temperature), filtered (48–52-micron pore size mesh filter), then centrifuged at 15,000
× g for 5 min before 25 μL of supernatant was sent for MS analysis. Sputum cell viability
was determined with the use of a Neubauer hemacytometer and Trypan Blue exclusion
staining.
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Human bronchial epithelial cultures
Human excess donor lungs and excised recipient lungs were obtained at the time of lung
transplantation from portions of main stem or lobar bronchi, and cells were harvested by
protease digestion (12). Cells were seeded directly as primary cultures on 12-mm Transwell
Col membranes (T-Col, Costar, Cambridge, MA) in modified bronchial epithelial growth
medium under airway liquid interface conditions and maintained at an air-liquid interface;
cultures were typically used 2–5 weeks after seeding. At this time, the cultures had a
differentiated morphology, including a distinct ASL/mucus layer indistinguishable from
ASL in vivo.
2R4F cigarettes
The development of the 1R4F cigarette was a joint effort by the National Cancer Institute
Agriculture Research Service-USDA and the Tobacco and Health Research Institute. The
blend specifications for this cigarette [Flue-cured 32.51%; Burley 19.94%; Maryland 1.24%;
Oriental 11.08%; Reconstituted (Schweitzer) 27.13%; Glycerin 2.80%; Invert sugar 5.30%]
were based on achieving a design for a cigarette that would deliver approximately 9.2 mg of
particulates and 0.8 mg of nicotine. These consistent levels were achieved through filtration,
air dilution, and blend selection (Tobacco Research and Development Center, University of
Kentucky, Lexington, KY). The 2R4F is the second run of the 1R4F.
Preparation and exposure of HBECs to whole and gaseous phase of cigarette smoke
WCS was prepared by smoking 2R4F cigarettes to ISO standard conditions [Routine
analytical cigarette-smoking machine—Definitions and standard conditions (ISO
3308:2000)]. This consisted of a 35-mL puff taken over a 2 s duration, and one “puff” every
60 s was applied to the cultures using a Borgwaldt LM1 diluter smoke engine. To generate
the GPCS, a Cambridge Filter pad, which retains 99.9% of all particulate matter with a size
greater than 0.1 μm, was inserted into the smoke line. Both WCS and GPCS were
transferred directly to the apical surface of cultures, which were contained in a specially
designed Perspex smoking chamber, keeping the cultures at an air-liquid interface (Figure
1). Unless stated otherwise, WCS and GPCS were applied to the cultures for the time it took
for one cigarette to burn, using ISO standard conditions (approximately 10 min and 11
“puffs”). WCS was diluted by a Borgwaldt smoke engine to various dilutions (1:3, 11: 0,
1:30, 1:100) using room air. After “smoking”, in order to measure nicotine and cotinine
levels, 500 μL Ringers solution was lavaged over the culture’s apical surface and incubated
at 37°C for 10 min (i.e., the time between start of smoking and sample collection was a total
of 20 min). In some instances, the lavage was frozen at −20°C prior to MS.
Preparation of CSC
CSC was prepared by smoking 2R4F cigarettes using ISO standard conditions of a 35-mL
puff taken over a 2 s duration and one “puff” every 60 s. The total particulate matter from
each of the cigarettes was collected onto Cambridge filter pads. The condensate was
extracted with DMSO to yield a concentration of 10 mg/mL and frozen immediately at
−80°C. The apical surfaces of cultures were exposed to 20 μL 1 μg/mL CSC for either 10
min or 1 h, before 500 μL Ringers solution was lavaged over the culture’s apical surface and
frozen at −20° prior to MS. Additionally, 500 μL of basolateral Ringers solution was
collected at the end of the time points and frozen at −20°C. In the literature, concentrations
of CSC used varies considerably (~0.1 μg/mL to ~20 μg/mL) (13,14); 0.4 μg/mL is a
concentration that has been shown in airway epithelial cells (A549) to have > 90% survival
and < 5% apoptosis (13); we chose a higher concentration (1 μg/mL) that has been shown to
not result in significant apoptosis of the cells, but is representative of a concentration
commonly used in in vitro studies (13).
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Measurement of particulate matter
To measure the amount of particulate matter in WCS and a 1:30 dilution of WCS, a pre-
weighed Teflo TM particle collection filter (47 mm, 2.0 μm, P/N R2PJ047, Pall Life
Sciences, East Hills, NY) was placed in front of the “smoke-in” port of the tissue culture
chamber and particulates were collected over the set-exposure time (10 min) of one
cigarette. After collection, the filters were re-weighed and the amount of particulates per
smoke volume calculated.
Measurement of nicotine in WCS and GPCS
Nicotine was measured using the method of Hammond and Leaderer (15). In brief,
particulate nicotine was collected on a 37-mm Cambridge glass filter, while vapor phase
nicotine was collected downstream on a similar filter that had been treated with sodium
bisulfate. A watchglass was filled with an aqueous solution of 4% sodium bisulfate, the filter
was placed on the surface of the solution for a few seconds, until it had absorbed the
solution, and then the filter was placed on a clean glass plate to dry. This method coated the
filter with 7–10 mg of sodium bisulfate. The two filters were contained within one cassette
and were separated by a stainless steel support screen and a Teflon o-ring.
Desorption of nicotine from treated filters
Treated filters were place in centrifuge tubes containing 2 mL of water and 100 μL of
ethanol and vortex mixed for 1 min. Two milliliters of 10 N sodium hydroxide was added to
form the free base of nicotine, and again vortex mixed for 1 min. Nicotine was then
concentrated by a liquid–liquid extraction into heptanes by adding 250 μL of ammoniated
heptane (gaseous ammonia was bubbled though heptanes for 30 s) and vortex mixing for an
additional min. An aliquot of the heptanes layer was removed immediately for analysis by
gas chromatography.
Desorption of nicotine from particulate matter
Filters containing the particulate matter collected were desorbed ultrasonically in
dichloromethane. Solutions were evaporated to 1 mL, and an aliquot of the solution was
taken for analysis.
Measurement of HBEC viability and morphology after WCS exposure
For the viability assay, cells were stained with 5 μM propidium iodide for 10 min at 37°C.
Cultures were imaged and then exposed to WCS for 10 min, followed by further 10 min
incubation at 37°C before being imaged again. As a non-viable cell control, 70% ethanol
was added to the WCS-exposed cultures before imaging. To label the morphology of live
cells, cultures were incubated for 30 min with 3 μM Calcein-AM at 37°C and then rinsed
(3×) with PBS. Cultures were imaged and then exposed to WCS for 10 min, followed by a
further 10 min incubation at 37°C before being imaged again. To observe any subtle
morphological changes, HBECs that had or had not been exposed to 10 min WCS were
fixed for 1 h in osmium tetraoxide in perfluorcarbon before being processed by conventional
methods for light microscopy and stained with Richardson’s stain. Cultures were imaged
using 100× lens.
Standards and reagents
Nicotine, cotinine, cimetidine, and all salts were obtained from Sigma-Aldrich (St. Louis,
MO). Nicotine and cotinine solutions (1 mM) were prepared in ethanol; dilutions required
for the standard curve (50 μM, 10 μM, 5 μM, 1 μM, 500 nM, 250 nM, 100 nM, 50 nM, and
25 nM) were made using standard Ringers solution. The internal standard, cimetidine, was
prepared at 10 nM in methanol.
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Nicotine and cotinine concentrations were determined by HPLC–MS–MS. The system
consisted of two Shimadzu Scientific (Columbia, MD) solvent delivery pumps, a Valco
(Houston, TX) switching valve, a thermostated (6°C) LEAP HTC autosampler (Carrboro,
NC), and an Applied Biosystems (Foster City, CA) API4000 triple-quadrupole MS.
Reversed-phase gradient chromatography was used to elute the compounds from an Aquasil
(C18, 5 μm, 50 × 2.1 mm) analytical column at a flow rate of 0.5 mL/min, following a 5-μL
injection. Starting conditions for each injection were 100% water with 0.1% formic acid (v/
v). This was held constant for 0.5 min while the column eluted to waste. After 0.5 min, the
eluent was directed to the MS and the organic phase (methanol with 0.1% formic acid, v/v)
increased linearly, reaching 90% organic 2 min post-injection. This was held for 1 min to
wash the column. The column was re-equilibrated to starting conditions for the final 1 min.
Total run time was 4 min. The MS was connected to the HPLC system by a TurboIonSpray
interface. Nitrogen, from a Peak Scientific (Bedford, MA) nitrogen generator, was used as
the curtain, nebulizer, and collision gases. User-controlled voltages, gas pressures, and
source temperature were optimized via direct infusion for nicotine, cotinine, and cimetidine.
All compounds were analyzed in positive ion mode using the following transitions preset in
multiple reaction monitoring scans: nicotine 163.1 → 84.5, cotinine 177.2 → 80.45, and
cimetidine 253.1 → 117.0. Automated sample acquisition and data analysis were performed
using Analyst software (version 1.4.1, Applied Biosystems). Calibration curves were
generated based on peak-area ratios (analyte: cimetidine) from 50 nM to 50 μM. Curves for
both nicotine and cimetidine followed a quadratic fit with 1/x weighting. Typical r values
were 0.997 or greater, and accuracy was between 90 and 110%. Automated sample
acquisition and data analysis were performed using Analyst software (version 1.4.1, Applied
Biosystems).
Statistical methods
All data is presented as mean ± standard error. Statistically, significance between groups
was assessed using non-parametric Student’s unpaired t test and equivalence was used when
appropriate. Data were inspected by analysis of variance to demonstrate whether or not the
data was derived from a single population and normally distributed. Values of n refer to the
number of experiments in each group.
Results
In vivo nicotine and cotinine concentrations
Concentrations of nicotine and cotinine in the ASL in vivo following exposure to WCS have
not previously been reported. We sampled induced sputum that is not contaminated with
saliva, as it has previously been shown to be comparable to ASL from bronchial surfaces
(8). However, based on reported plasma and serum nicotine levels (16), it was predicted that
a method with a limit of quantification of 5 nM to 5 μM would be sufficient to analyze this
parameter. We collected induced sputum from subjects immediately (i.e., within 5 min) after
they smoked one full cigarette, to determine the concentrations of nicotine and cotinine after
WCS deposition in the ASL in vivo. Levels of nicotine found in induced sputum were 33.6
± 5.5 μM (n = 12) (Figure 4A), whereas cotinine concentrations were found to be
significantly lower (6.5 ± 1.1 μM; n = 12) (Figure 4B).
WCS does not affect HBEC viability, integrity, or morphology
To test whether WCS affected the viability or morphology of live HBECs, we loaded
cultures with either propidium iodide or Calcein-AM before exposing them to WCS. We
then used fluorescence microscopy to measure changes in HBEC properties pre/post WCS
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exposure. To determine whether WCS exposure caused any subtle changes on HBEC
morphology, we also fixed HBECs ± WCS in Osmium Tetraoxide in perfluorocarbon. The
sections of these cultures were then stained with Richardsons stain and imaged using a 100×
lens. Using these approaches, it appeared that exposure of HBECs to WCS did not affect
either the viability or morphology of either the live or fixed cultures (Figure 2).
Concentrations of nicotine and cotinine in airway surface liquid in vitro
To determine the concentrations of nicotine and cotinine in the ASL after WCSe exposure,
we exposed the apical surface of HBECs to varying dilutions of WCS (see Preparation and
exposure of HBECs to whole and gaseous phase of cigarette smoke). The amount of nicotine
detected in ASL decreased as the smoke was diluted by the smoke engine, but remained in
the micromolar range (WCS, 336.8 ± 10.4 μM; 1:3 dilution, 261.3 ± 1.2 μM; 1:10 dilution,
40.9 ± 0.1 μM; 1:30 dilution, 37.1 ± 0.2 μM; 1:100 dilution, 11.8 ± 0.5 μM; n = 4). (Figure
3A). ASL cotinine concentrations in HBECs exposed to smoke were much lower than
nicotine, and at 1:100 dilution of WCS, cotinine was not detected (WCS, 3.2 ± 0.006 μM;
1:3 dilution, 2.6 ± 0.02 μM; 1:10 dilution, 0.6 ± 0.008 μM; 1:30 dilution, 0.5 ± 0.01 μM;
1:100 dilution, no peak; n = 4) (Figure 3B).
Comparison of in vitro and in vivo nicotine and cotinine concentrations
To test whether our smoke exposure system provided comparable ASL nicotine and cotinine
concentrations to what occurs in vivo, we compared the nicotine and cotinine concentrations
found in induced sputum to ASL samples collected from HBECs exposed to various
dilutions of cigarette smoke (all samples were collected approximately 10–20 min after
smoke exposure). Levels of nicotine in induced sputum were not significantly different from
those found after a 1:30 dilution of WCS (induced sputum, 33.6 ± 5.5 μM; 1:30 dilution,
37.1 ± 0.2 μM; n = 4) (Figure 3A). This was in contrast to cotinine concentrations, which
were significantly lower in in vitro (1:30 dilution) samples compared to in vivo samples
(induced sputum, 6.5 ± 1.1 μM; 1:30 dilution, 0.5 ± 0.02 μM; n = 4) (Figure 3B).
A comparison of nicotine dosing using different methods of smoke production
To evaluate different methods of smoke exposure, we measured nicotine exposure levels in
ASL from HBECs and induced sputum samples exposed to WCS, GPCS, and CSC (at two
different time points). The amount of nicotine found in GPCS and the 1 h CSC exposed
cultures was significantly lower than the nicotine found in either the 1:30 dilution of WCS
or the induced sputum from cigarette smokers (1:30 dilution, 37.1 ± 0.2 μM; GSC, 19.4 ±
0.1 μM, CSC, 0.1 ± 0.007 μM; induced sputum, 33.6 ± 5.5 μM; n = 4; P < 0.05), suggesting
that the WCS exposure yields concentrations of nicotine that are more comparable to the in
vivo measurements. In contrast, ASL concentrations of cotinine from WCS, GPCS, and 1 h
CSC-exposed cultures were all significantly lower from that seen in vivo (1:30 dilution, 0.5
± 0.02 μM; GSC, 0.3 ± 0.01 μM; CSC, 0.2 ± 0.01 μM; induced sputum, 6.5 ± 1.1 μM; n = 4)
(Figure 4B), suggesting that nicotine is not metabolized to cotinine in vivo. Cotinine levels
were found to be significantly lower than nicotine levels in all samples apart from those
treated with CSC. Levels of both nicotine and cotinine in the samples collected from the
cultures exposed to CSC for 10 min were both below the limit of detection of our system
(i.e., < 5 nM).
Concentration of nicotine and particulate matter in WCS and 1:30 dilution of WCS
In order to make it easier for other researchers to replicate our exposure system, we
measured the concentration of nicotine and particulate matter our system produces in both
WCS and a 1:30 dilution of WCS. The amount of particulate matter found in WCS was 74.1
± 16.6 mg/m3 compared to 26.5 ± 0.3 mg/m3 from the 1:30 dilution. The concentrations of
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nicotine and cotinine in both the particulate and gaseous phases of WCS and the 1:30
dilution of WCS at the ‘smoke-in’ port of our tissue culture chamber were also determined.
Levels of nicotine were found to be higher in WCS than the 1:30 dilution for both the
particulate (WCS, 315.3 ± 18.2 μM; 1:30 dilution, 82.5 ± 2.2 μM) and gaseous (WCS, 838.4
± 62.4 μM; 1:30 dilution, 400.6 ± 91.4 μM) phases. The same pattern was seen for cotinine
levels (particulate phase: WCS, 3.5 ± 0.3 μM; 1:30 dilution, 0.8 ± 0.04 μM; gaseous phase:
WCS, 0.9 ± 0.2 μM; 1:30 dilution, 0.6 ± 0.2 μM). Levels of nicotine and cotinine measured
in 1 μg/mL CSC were 4.98 ± 0.4 μM and 0.2 ± 0.003 μM, respectively, which were
significantly lower than levels seen in either whole or 1:30 dilution of WCS.
Discussion
The superficial epithelium which lines the airways is the principle site of WCS deposition
(17). Recent reports have shown that airway epithelia themselves can be directly altered by
smoke exposure (6,7). However, methods of delivering cigarette smoke to cultured airway
epithelial cells varies substantially between laboratories. Our study not only highlights the
need for a standardized method for cigarette smoking in vitro, but suggests that WCS is the
most appropriate method.
Cigarette smoke exposure is most often performed using lipid soluble (CSC) or aqueous
extracts of cigarette smoke to treat cells in preference to WCS, because these methods have
the advantage of being relatively easy to perform and reproduce. CSC is currently the most
common vehicle for delivering components of cigarette smoke (7,19–21). However, these
methodologies only utilize ~5% of the components of WCS. We reasoned that a system
capable of accurately administering 100% of WCS in a reproductive fashion to apical
surfaces of well-differentiated HBECs is required before being able to test the effects of
cigarette smoke on airway epithelia in vitro. Accordingly, we compared the system
developed by Phillips et al. (10) (Figure 1) to WCS deposition in vivo ASL (induced
sputum) obtained from smokers directly after consumption of one cigarette. Nicotine
appears to be present in substantial quantities in both WCS and CSC and is one of the more
relatively stable constituents of cigarette smoke (18). Using nicotine as a marker of cigarette
smoke exposure, we demonstrated that the amount of “smoke components” that come in
contact with the ASL differs substantially depending on the preparation of smoke delivered.
It should be noted, however, that while nicotine is a useful marker of cigarette smoke
exposure, its levels may not reflect levels of other toxic chemicals in cigarette smoke, and
toxicological effects of cigarette smoke preparations may not be proportional to nicotine
levels in ASL. We were able to show that, in contrast to CSC where the amount of nicotine
measured in the ASL of HBECs exposed to CSC is significantly different from
concentrations measured in vivo, the nicotine concentrations found in the ASL of HBECs
exposed to a 1:30 dilution of WCS were comparable to levels measured in vivo, confirming
our hypothesis that the use of WCS has more toxicological relevance.
A model to predict the percent deposition of cigarette smoke particles in the airways was
developed by the Task Group on Lung Dynamics (1966), which predicted that
approximately 30% of the particulates will deposit in the alveolar region and 5–10% in the
tracheobronchial region (22). Thus, a 1:30 (or 3%) dilution of WCS is close to the amount of
particulates/nicotine that would reach bronchial epithelial cells in vivo (i.e., ≥ 5%).
Previously published reports have estimated that the concentration of nicotine in the alveolar
lining fluid is 1–10 μg/mL (~6–60 μM) after smoking one cigarette (18,23,24), which is
consistent with the values we have measured in vitro and in vivo in the ASL under similar
conditions. Smokers chosen for this study were light (i.e., less than one pack/year).
However, it is important to consider that the concentration of nicotine could be higher in
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chronic smokers because of its possible accumulation in the ASL at rates faster than it can
be cleared by the airways.
Our study suggests that nicotine does not get converted to cotinine in freshly produced
cigarette smoke in the ASL of HBECs after WCS exposure. This is not surprising, as
nicotine is primarily metabolized in the liver by cytochrome P450 enzymes in vivo and this
is likely the primary site of cotinine production, rather than the lungs. However, more
cotinine than nicotine was detected in CSC-exposed ASL in vitro, suggesting that
components of CSC may continue to react once CSC has been collected. This CSC may
actually have a very different composition when applied to cells that are time-dependent. In
support of this hypothesis, it is estimated that cigarette smoke contains over 1017 small
oxygen- and carbon-centered free radicals in each puff of smoke (1,2) and although the half-
life of most oxygen-free radicals is short (< 1 s), Church and Pryor (2) demonstrated the
presence of cigarette smoke free radical activity in extracts, and postulated that continuous
free radical regeneration occurs in the extract form. WCS also likely reacts with itself after
production. However, in our system, it is delivered to culture surfaces within seconds after
production in a similar fashion to in vivo and was never stored for subsequent usage.
Interestingly, although nicotine is thought to reside only in the particulate phase of cigarette
smoke, we were still able to detect nicotine in samples exposed to GPCS, indicating that
either nicotine is present in the gaseous phase or that the filters used to generate the gaseous
phase do not remove 100% of all nicotine. Nicotine concentrations from GPCS-exposed
cultures were significantly different to both in vivo and WCS-exposed cultures, but were
significantly higher than those found in CSC-exposed cultures. This observation was
confirmed by measuring nicotine directly from the “smoke-in” port of the tissue culture
chamber in both the particulate and gaseous phases. Nicotine appeared to be present in
higher concentrations in the vapor phase than in the particulate phase, suggesting that either
the filters used to collect CSC are not sufficient in removing all particulates, or that nicotine
is indeed present in both particulate and gaseous phases. These observations suggest the
need for further investigation.
In conclusion, using nicotine as a marker of cigarette smoke exposure, we have
demonstrated that we can reproducibly deliver WCS to the ASL of well-differentiated
HBECs in a dose-dependent manner. Furthermore, we can adjust the dosing to match in vivo
exposure levels. We conclude that the smoke exposure system designed by Phillips et al.
(10) recapitulates normal smoking and should permit reliable/reproducible studies of WCS
in vitro.
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Diagrammatic representation of the whole cigarette smoke exposure chamber. The chamber
was attached to a Borgwaldt LM1 diluter smoke engine via the “smoke in” tube and smoke
was evenly distributed over the apical surfaces of the cultures, by means of the distribution
plate. During this time, warmed (37°C) culture medium continuously flowed across the
serosal surfaces of the cultures. The horizontal medium inflow tube was below the level of
the culture inserts, while the bottom of the vertical outflow tube was fractionally above the
base of the inserts, to ensure the level of medium remained constant (10).
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WCS does not affect HBEC integrity. Viability (A). All cultures (control cultures, cultures
10 min after undiluted WCS exposure and WCS-exposed cultures after addition of 70%
ethanol) were stained with 5 μM propidium iodide, which fluoresces upon binding to DNA
of dead cells (all images are representative from n = 4 cultures per group). Integrity (B).
Calcein-stained live HBECs imaged by confocal microscopy pre- (top) and post- (bottom)
10-min WCS exposure (all images are representative from n = 4 cultures per group).
Morphology (C). Control HBECs and HBECs exposed to WCS for 10 min were fixed in 1%
osmium tetraoxide suspended in perfluorocarbon and stained with Richardson’s stain before
being imaged by light microscopy with 100× lens.
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Concentrations of nicotine and cotinine in ASL (in vitro) after cigarette smoke exposure. All
cultures were exposed to WCS under thin-film conditions then ASL obtained by lavage.
Nicotine in WCS (336.8 ± 10.4 μM); 1:3 (261.3 ± 1.2 μM); 1:10 (40.9 ± 0.1 μM); 1:30 (37.1
± 0.2 μM); 1:100 (11.8 ± 0.5 μM) (A). Cotinine in WCS (3.2 ± 0.006 μM); 1:3 (2.6 ± 0.02
μM); 1:10 (0.6 ± 0.008 μM); 1:30 (0.5 ± 0.01μM); 1:100 (no peak) (B). n = > 4 for all
conditions.
Clunes et al. Page 13














Concentrations of nicotine and cotinine in airway epithelial cells (in vitro) versus induced
sputum (in vivo) after cigarette smoke exposure. ASL was obtained by lavage in vitro or
following induction of sputum in vivo. Nicotine in induced sputum (33.6 ± 5.5 μM); 1:30
dilution of WCS (37.1 ± 0.2 μM); GPCS (19.4 ± 0.1 μM); CSC (0.1 ± 0.007 μM) (A).
Cotinine in induced sputum (6.5 ± 1.1 μM); 1:30 dilution of WCS (0.5 ± 0.02 μM); GPCS
(0.3 ± 0.01μM); CSC (0.2 ± 0.01 μM) (B). n = > 4 for all conditions.
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